Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol
Endometrioma Ethanol Sclerotherapy and Its Effect on Ovarian Function and Fertility Treatment Outcome - Prospective Cohort Study Protocol
Hillel Yaffe Medical Center
120 participants
Aug 9, 2022
OBSERVATIONAL
Conditions
Summary
Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.
Eligibility
Inclusion Criteria1
- A woman with endometrioma with a diameter of 25-100 mm
Exclusion Criteria1
- Other causes of infertility (sperm disorder, ovulation disorder, uterine disorder, mechanical factor, poor ovarian reserve)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
ultrasound (US)-guided sclerotherapy for the treatment of ovarian endometrioma
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06971458